This site is optimised for modern browsers. For the best experience, please use Google Chrome, Mozilla Firefox, or Microsoft Edge.


We welcome your feedback, which will help improve this site.

Feedback form

Efficacy and Mechanism Evaluation (EME) Programme welcomes new Chair


Professor John Norrie has been appointed as the new Chair of the Efficacy and Mechanism Evaluation (EME) Funding Committee. 

Professor Norrie, Chair of Medical Statistics and Trial Methodology Director at the University of Edinburgh, will take up the role on 1 August 2019, subject to successful completion of the contractual process, serving a three-year term of office. He will succeed Professor David Crossman, following an interim period when the EME Programme Director, Professor Danny McAuley served as Interim Chair.

The EME Programme is a Medical Research Council (MRC) and NIHR partnership. The Programme funds ambitious studies evaluating interventions with potential to make a step-change in the promotion of health, treatment of disease and improvement of rehabilitation or long-term care. Members of the EME Funding Committee consider applications received from the UK clinical and scientific research community for clinical trials and evaluative studies in patients, to test the clinical efficacy of interventions and develop new methodologies. The Committee makes funding decisions based on external review and the Committee discussion.

Professor Norrie has an accomplished track record of producing high quality medical research and trial methodology at The University of Edinburgh and Co-Heads the Centre for Population Health Sciences. He specialises in genetic, molecular and population health sciences and has previously worked with the NIHR in a number of areas including supporting the NIHR’s work as a member of the Health Technology Assessment (HTA) Funding Committee.

EME Programme Director and Interim Chair, Professor Danny McAuley said: “I am delighted that John has accepted this position. The EME Programme supports the translation of early research findings to improve patient outcomes and I look forward to working with him on shared research priorities.”

Commenting on his appointment, Professor Norrie said: “I am delighted to have the opportunity to chair this important committee and look forward to supporting the programme’s research portfolio, alongside developing new relationships with key partners.”

More information on the programme is available on the NIHR website.